The authors noted that the available studies allowed only for indirect comparison among the different anti-TNF agents. Therefore, they were unable to make a conclusion about the differences among the drugs with regard to key benefit or harm outcomes. (posted 5/8/15)
You Might Also Like
Explore This IssueJune 2015
Also By This Author
Dr. Pullen is a medical writer based in the Chicago area.
1. Maxwell LJ, Zochling J, Boonen A, et al. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015. Apr 18. doi: 10.1002/14651858.CD005468.pub2. [E pub before print].